| | 
Part, Chapter, Paragraph
1 -, 1 | have been published:~a) in 2003, “The Health Status of the
2 I, 2. 2 | turned negative in 2001 and 2003 they continued growing in
3 I, 2. 5 | published in early October 2003, presented a panorama of
4 I, 2. 6 | ISCED levels 5 or 6) in 2003/2004~ ~This gap is evident
5 I, 2. 6 | increased between 1997/98 and 2003/04 in virtually all countries
6 I, 2. 6 | almost 47% of students in 2003-04. In Belgium and the Czech Republic
7 I, 2. 6 | Iceland. Between 1997/98 and 2003/04, the number of women
8 I, 2. 6 | 91.6 millions in 2002 and 2003 respectively to 71.7 millions
9 I, 2. 7 | NMS or Turkey (EUROSTAT, 2003). EURIPA, the European Rural
10 I, 2. 9 | e.g. the summer heat of 2003 and the spring drought of
11 I, 2. 10. 4 | dispensing system in May 2003. A study in the hospital
12 I, 2. 11 | Available at: ftp ~ ~EUROSTAT (2003): Eurostat yearbook 2003,
13 I, 2. 11 | 2003): Eurostat yearbook 2003, the statistical guide to
14 I, 2. 11 | yearbook 2005. Data 1999-2003. [on-line publication available
15 II, 4. 1 | Jagger and Euro-REVES, 2003; Robine et al, 2003).~ ~
16 II, 4. 1 | Euro-REVES, 2003; Robine et al, 2003).~ ~Following the adoption
17 II, 4. 1 | Jagger and Euro-REVES, 2003) and is to be a subset of
18 II, 4. 1 | Jagger and Euro-REVES, 2003). All data (death counts,
19 II, 4. 1 | expectancies (Robine et al, 2003), on both sides of the North
20 II, 4. 3 | M., C. Jagger, et al. (2003): Creating a coherent set
21 II, 4. 3 | C. Jagger, et al., Eds. (2003): Determining health expectancies.
22 II, 4. 3 | and the Euro-REVES Group (2003): Creating a coherent set
23 II, 4. 3 | Journal of Public Health 2003; 13:6-14.~ ~Robine, J.-M.,
24 II, 5. 1. 1 | death; 3 years average (2001-2003), EU27 – A) Women~ ~Figure
25 II, 5. 1. 1 | death; 3 years average (2001-2003), EU27 – B) Men.~ ~ ~ ~Table
26 II, 5. 1. 1 | HPV (Stewart and Kleihues, 2003). Genital HPV is usually
27 II, 5. 1. 1 | race (Stewart and Kleihues, 2003).~ ~Other types of cancer:
28 II, 5. 1. 1 | COPD.A study by Lundback (2003) showed that age and smoking
29 II, 5. 2. 2 | 3 years available (2001-2003) in the European Union (
30 II, 5. 2. 2 | the last ten years (1994-2003) to estimate trends. Thus,
31 II, 5. 2. 2 | the three year period 2001-2003 along with those already
32 II, 5. 2. 2 | the last year available (2003) are reported. Other data,
33 II, 5. 2. 2 | The last ten years (1994-2003) were selected to estimate
34 II, 5. 2. 2 | the last year available (2003) are reported.~The ICD morbidity
35 II, 5. 2. 3 | the most recent data (2001-2003), the rates vary from 42.
36 II, 5. 2. 3 | all countries from 1994 to 2003 mortality rates in the 35-
37 II, 5. 2. 3 | Eurociss Working Group, 2003).~ ~Table 5.2.4. WHO-MONICA
38 II, 5. 2. 3 | Figure 5.2.3; from 1994 to 2003 mortality rates in the age
39 II, 5. 2. 3 | to 357 per 100.000). In 2003, mortality rates in Central
40 II, 5. 2. 3 | to 246 per 100.000). In 2003, mortality rates in Southern
41 II, 5. 2. 3 | disease severity (Sarti et al, 2003).~ ~Table 5.2.6. WHO-MONICA
42 II, 5. 2. 5 | factors (Greenland et al, 2003), and optimal levels of
43 II, 5. 2. 6 | significant (Turnbull S et al, 2003). Lifestyle improvement
44 II, 5. 2. 6 | Trialists' Collaboration (2003). Effects of different blood-pressure-lowering
45 II, 5. 2. 7 | EUROCISS Project final report 2003 updated May 2006 [htt ] (
46 II, 5. 2. 7 | EUROCISS Working Group (2003): Coronary and cerebrovascular
47 II, 5. 2. 7 | Garside DB, and. Wilson PW (2003): Major risk factors as
48 II, 5. 2. 7 | the WHO MONICA Project (2003): Are changes in mortality
49 II, 5. 3. 1 | in the near future (WHO, 2003; Micheli, Baili et al, 2003).~ ~
50 II, 5. 3. 1 | 2003; Micheli, Baili et al, 2003).~ ~Main indicators to describe
51 II, 5. 3. 1 | Micheli, Capocaccia et al, 2003), in this chapter cancer
52 II, 5. 3. 2 | project (Capocaccia et al, 2003; Sant et al, 2003; Berrino
53 II, 5. 3. 2 | et al, 2003; Sant et al, 2003; Berrino et al, 2007)~ ~·
54 II, 5. 3. 3 | EUROCARE project (Sant et al, 2003; Berrino et al, 2007; Verdecchia
55 II, 5. 3. 4 | HPV (Stewart and Kleihues, 2003). Genital HPV is usually
56 II, 5. 3. 4 | race (Stewart and Kleihues, 2003).~ ~
57 II, 5. 3. 5 | infection (Stewart and Kleihues, 2003). Cervical cancer incidence
58 II, 5. 3. 6 | Eastern Europe (Sant et al, 2003).~ ~Figure 5.3.29a. All
59 II, 5. 3. 6 | post-operative mortality (Sant et al, 2003).~ ~Figure 5.3.30a. Stomach
60 II, 5. 3. 6 | cancer sites (Sant et al, 2003).~ ~Figure 5.3.31a. Colorectal
61 II, 5. 3. 6 | 8% in women (Sant et al, 2003).~ ~Figure 5.3.32a. Lung
62 II, 5. 3. 6 | 60 and 67% (Sant et al, 2003).~Relative survival for
63 II, 5. 3. 6 | increased (Coleman et al, 2003).~ ~Figure 5.3.33. Female
64 II, 5. 3. 6 | Figure 5.3.34) (Sant et al, 2003). Survival has improved
65 II, 5. 3. 6 | treatment (Coleman et al, 2003).~ ~Figure 5.3.34. Cervical
66 II, 5. 3. 6 | survival (<55%) (Sant et al, 2003). European 5-year relative
67 II, 5. 3. 6 | incidence levels (Sant et al, 2003; Coleman et al, 2003).~ ~
68 II, 5. 3. 6 | al, 2003; Coleman et al, 2003).~ ~Figure 5.3.35. Prostate
69 II, 5. 3. 6 | followed up to December, 2003.~Age-adjusted 5-year relative
70 II, 5. 3. 7 | strategies and actions (WHO, 2003). The first phase to plan
71 II, 5. 3. 7 | are all recommended by the 2003 European Code Against Cancer
72 II, 5. 3. 7 | the disease (Boyle et al, 2003).~ ~See Chapter 10 for primary
73 II, 5. 3. 7 | for colorectal cancer. In 2003 the European Council published
74 II, 5. 3. 7 | programmes (European Council, 2003). Recommendations referred
75 II, 5. 3. 7 | health care (Coleman et al, 2003).~Estimating the range of
76 II, 5. 3. 7 | health care (Coleman et al, 2003). Therefore, it is fundamental
77 II, 5. 3. 7 | stage~CZECH REPUBLIC~Yes (2003)~DENMARK~Yes~GERMANY~No~
78 II, 5. 3. 8 | recent years (Coleman et al, 2003). Cancer prevalence, the
79 II, 5. 3. 9 | Autier P, Bartelink H, et al (2003): European Code Against
80 II, 5. 3. 9 | EUROCARE Working Group (2003): EUROCARE-3 summary. Cancer
81 II, 5. 3. 9 | 2008).~ ~European Council (2003): Council recommendation
82 II, 5. 3. 9 | recommendation of 2 December 2003 on cancer screening. htt f (
83 II, 5. 3. 9 | EUROCARE Working Group (2003): Life expectancy and cancer
84 II, 5. 3. 9 | A, Berrino F, Coleman M (2003): Cancer control in Europe:
85 II, 5. 3. 9 | EUROCARE Working Group (2003): EUROCARE-3: survival of
86 II, 5. 3. 9 | Stewart BW, Kleihues P (2003): World Cancer Report. WHO
87 II, 5. 3. 9 | Washington DC: AICR.~ ~WHO (2003): Strategies to improve
88 II, 5. 4. 2 | Gudbjörnsdottir et al. 2003) and Denmark (Carstersen
89 II, 5. 4. 6 | national basis (de Beaufort 2003). The final report, published
90 II, 5. 4. 6 | adequate treatments. The WHO 2003 report defines screening
91 II, 5. 4. 8 | October 2008)~De Beaufort CE (2003): European Union diabetes
92 II, 5. 4. 8 | National Diabetes Register (2003), The National Diabetes
93 II, 5. 4. 8 | Diabetes Care.Diabetes Care. 2003 Apr;26(4):1270-6.~Greenfield
94 II, 5. 5.Int | problem (European Commission 2003), which range from mild
95 II, 5. 5.Int | policy initiatives20. The EU 2003-2008 Public Health Programme
96 II, 5. 5.Int | People with Disabilities in 2003; and (iii) The adoption
97 II, 5. 5. 1 | Fryers, 2007, Blakely et al, 2003) although there are other
98 II, 5. 5. 1 | individual (e.g. Blakely et al 2003) and even at community level (
99 II, 5. 5. 1 | Violence Epidemiology (1999-2003), evaluated the quality
100 II, 5. 5. 1 | Collings SC, Atkinson J (2003). Unemployment and suicide.
101 II, 5. 5. 3 | body characteristics” (WHO, 2003).~Eating disorders such
102 II, 5. 5. 3 | 2007; Hoek and van Hoeken, 2003).~ ~Reviewed articles and
103 II, 5. 5. 3 | by Hoek and van Hoeken (2003) for several Western and
104 II, 5. 5. 3 | by Hoek and van Hoeken (2003) for several Western and
105 II, 5. 5. 3 | low (Hoek and van Hoeken, 2003). An average prevalence
106 II, 5. 5. 3 | rising (Hoek and van Hoeken, 2003). Time trends in incidence
107 II, 5. 5. 3 | 1990 (Hoek and van Hoeken, 2003). Hoek and van Hoeken (2003)
108 II, 5. 5. 3 | 2003). Hoek and van Hoeken (2003) reported a significant
109 II, 5. 5. 3 | 000 (Hoek and van Hoeken, 2003).~The HBSC (Health Behaviour
110 II, 5. 5. 3 | Hoek H W, van Hoeken D, (2003): Review of the Prevalence
111 II, 5. 5. 3 | Health Organization (WHO) (2003): Eating disorders. National
112 II, 5. 5. 3 | treatments (Lehman et al, 2003). Apart from the inadequacy
113 II, 5. 5. 3 | between July 2002 and June 2003 substantiate that only 30%
114 II, 5. 5. 3 | with schizophrenia (IMS 2003).~ ~ ~Health indicators
115 II, 5. 5. 3 | well it works (Spollen, 2003).~Domains reflecting this
116 II, 5. 5. 3 | 2007; Vauth, 2006,; Glynn, 2003; Pilling et al, 2002) –
117 II, 5. 5. 3 | Lehman and Steinwachs, 2003). The latter is in part
118 II, 5. 5. 3 | 2005; AGREE Collaboration, 2003) – see table 5.5.3.2.4.~
119 II, 5. 5. 3 | schizophrenia (Andrews et al, 2003). Their findings – 22% of
120 II, 5. 5. 3 | desirable (Wölwer et al, 2003)~Prevention~The WHO Report “
121 II, 5. 5. 3 | References~AGREE Collaboration (2003): Development and validation
122 II, 5. 5. 3 | Issakidis C, Lapsley H (2003): Cost-effectiveness of
123 II, 5. 5. 3 | 187: 248-255.~Glynn SM (2003): Psychiatric rehabilitation
124 II, 5. 5. 3 | Psychopathology 35:36-47~Lehman AF (2003): Overview of best practices:
125 II, 5. 5. 3 | Lehman AF, Steinwachs DM (2003): Evidence-based psychosocial
126 II, 5. 5. 3 | Psychiatry 153:214-7.~Spollen JJ (2003): The efficacy-effectiveness
127 II, 5. 5. 3 | W, Möller HJ, Gaebel W (2003): German Research Network
128 II, 5. 5. 3 | Spectrum Disorders in Spain in 2003. Journal of Autism and Development
129 II, 5. 5. 3 | examination~396 ~5.3 ~Oun et al., 2003 (*)~Finland~Adults ~MR review
130 II, 5. 5. 3 | 69 ~4.3 ~Tidman et al., 2003 (*)~+ = 5-14 years - = 6-
131 II, 5. 5. 3 | reached 39% (Vignatelli et al, 2003). Although the idiosyncratic
132 II, 5. 5. 3 | per 1,000 (Nilsson et al, 2003). There is some indication
133 II, 5. 5. 3 | difficulties (Anonymous, 2003). An old study made on the
134 II, 5. 5. 3 | Western Europe (Anonymous, 2003). These findings are in
135 II, 5. 5. 3 | could understand (Anonymous, 2003). The ILAE Employment Commission
136 II, 5. 5. 3 | state agencies (Anonymous, 2003). The elements of these
137 II, 5. 5. 3 | References~ ~Anonymous (2003): Living with epilepsy.
138 II, 5. 5. 3 | Farahmand BY, Tomson T (2003): Mortality in a population-based
139 II, 5. 5. 3 | results from meta-analysis 2003. Report to the Institute
140 II, 5. 5. 3 | Study of Status Epilepticus (2003): Incidence and short-term
141 II, 5. 5. 3 | Confavreux et al, 2000; 2003).~ ~The Norwegian National
142 II, 5. 5. 3 | County prevalence was 151 in 2003. In most Nordic counties
143 II, 5. 5. 3 | considered (Zivadinov et al, 2003). However, for prevalence
144 II, 5. 5. 3 | European Union~In December 2003 the European Parliament
145 II, 5. 5. 3 | Vukusic S, Adeleine P (2003): Early clinical predictors
146 II, 5. 5. 3 | Maltezos ES, Milonas IA (2003): Epidemiological data of
147 II, 5. 5. 3 | Perini P, Tzintzeva E et al (2003): Increasing frequency of
148 II, 5. 5. 3 | PJ, Hakama M, Wikström J (2003): Multiple sclerosis in
149 II, 5. 5. 3 | Nyström L, Forsgren L (2003): Incidence (1988-97): and
150 II, 5. 5. 3 | Monti-Bragadin L, et al (2003): The use of standardized
151 II, 5. 5. 3 | studies (Benito-Leon et al, 2003; Bergareche et al, 2004;
152 II, 5. 5. 3 | disease (Findley et al, 2003; Spottke et al, 2005). A
153 II, 5. 5. 3 | in detail (Twelves et al, 2003). Methodological differences
154 II, 5. 5. 3 | Logroscino, 2005; Tanner, 2003; Tanner and Aston, 2000).~
155 II, 5. 5. 3 | Gabriel R, Morales JM (2003): Prevalence of PD and other
156 II, 5. 5. 3 | DG, Peto V, Playfer JR (2003): Direct economic impact
157 II, 5. 5. 3 | Giuffrida S, Reggio A (2003): Prevalence of Parkinson’
158 II, 5. 5. 3 | 13(4):427-430.~Tanner CM (2003): Is the cause of Parkinson’
159 II, 5. 5. 3 | Perkins KS, Counsell C (2003): Systematic review of incidence
160 II, 5. 6. 2 | Start Of The New Millennium. 2003 WHO Technical Report Series
161 II, 5. 6. 2 | and Bone and Joint Decade, 2003 (European Commission (2003):
162 II, 5. 6. 2 | 2003 (European Commission (2003): Indicators for Monitoring
163 II, 5. 6. 3 | North America (Symmons, 2003) are given in table 5.6.
164 II, 5. 6. 3 | prevalence (Symmons et al, 2003). For example, a study of
165 II, 5. 6. 3 | attributed to OA (Symmons et al, 2003).~ ~Table 5.6.2. Osteoarthritis
166 II, 5. 6. 3 | procedures / 100,000 (Merx et al, 2003). The estimated requirement
167 II, 5. 6. 3 | knee disease (Juni et al, 2003).~ ~Future trends~ ~Future
168 II, 5. 6. 3 | criteria (European Commission (2003): Indicators for Monitoring
169 II, 5. 6. 3 | scapula (Woolf and Pfleger, 2003).~ ~
170 II, 5. 6. 3 | WHO Technical Report 919, 2003). There is a steep increase
171 II, 5. 6. 3 | fracture (Woolf and Akesson, 2003).~ ~Most hip fractures occur
172 II, 5. 6. 3 | prior functions (Melton, 2003; Sernbo and Johnell, 1993).
173 II, 5. 6. 3 | 33% (Woolf and Pfleger, 2003).~ ~Determinants, risk factors
174 II, 5. 6. 3 | months (Woolf and Pfleger, 2003), but the longer on sick leave,
175 II, 5. 6. 4 | 1994. (European Commission (2003): Indicators for Monitoring
176 II, 5. 6. 4 | European Commission (2003): Indicators for Monitoring
177 II, 5. 6. 6 | European Commission (2003): Indicators for Monitoring
178 II, 5. 6. 6 | Greenwood R, Frankel S (2003): Population Requirement
179 II, 5. 6. 6 | pp 225-47~Melton LJ, III (2003): Adverse outcomes of osteoporotic
180 II, 5. 6. 6 | Gunther KP, Brenner H (2003): International Variation
181 II, 5. 6. 6 | 760~Picavet HS, Hazes JM (2003): Prevalence of self reported
182 II, 5. 6. 6 | Mathers C, and Pfleger B (2003): Global Burden of Osteoarthritis
183 II, 5. 6. 6 | Health Organization~ ~WHO (2003): The Burden of Musculoskeletal
184 II, 5. 6. 6 | Elsevier,~Woolf AD, Akesson K (2003): Preventing fractures in
185 II, 5. 6. 6 | Woolf AD and Pfleger B (2003): Burden of Major Musculoskeletal
186 II, 5. 7. 1 | al, 2005; Chadban et al, 2003) indicate the problem is
187 II, 5. 7. 1 | complications (Chobanian et al, 2003; National Kidney Foundation,
188 II, 5. 7. 1 | 2002-2006; Sarnak et al., 2003; American Diabetes Association,
189 II, 5. 7. 1 | multiplier (Sarnak et al. 2003). Furthermore, evidence
190 II, 5. 7. 1 | microalbuminuria (Boulware et al, 2003; Gansevoort et al, 2005)
191 II, 5. 7. 1 | is rare (Ardissino et al, 2003; Esbjorner et al, 1997).
192 II, 5. 7. 3 | hypertensive ESRD (Stengel et al, 2003; van Dijk et al, 2005) After
193 II, 5. 7. 3 | areas (UK Renal Registry, 2003).~ ~Prevalence~ ~For the
194 II, 5. 7. 3 | sub-optimal (Lin et al, 2003).~ ~Children and adolescents~ ~
195 II, 5. 7. 3 | Chadha, 2007; Ardissino et al 2003). Data in a population-based
196 II, 5. 7. 3 | pmarp (Ardissino et al, 2003). In a survey in Sweden
197 II, 5. 7. 3 | Report UK Renal Registry, 2003; Warady and Chadha, 2007;
198 II, 5. 7. 3 | sub-optimal (Lin et al, 2003).~ ~Although there are considerable
199 II, 5. 7. 3 | hypertensive ESRD (Stengel et al, 2003; van Dijk et al, 2005) After
200 II, 5. 7. 4 | Registry (UK Renal Registry, 2003), the prevalence of RRT
201 II, 5. 7. 5 | cost-effective (Boulware et al, 2003; Atthobari et al, 2006).
202 II, 5. 7. 7 | Claris-Appiani A, Taioli E, et al (2003): Epidemiology of chronic
203 II, 5. 7. 7 | ItalKid project. Pediatrics 2003 Apr;111(4 Pt 1):e382-e387.~
204 II, 5. 7. 7 | ME, Brancati FL, Powe NR (2003): Screening for proteinuria
205 II, 5. 7. 7 | cost-effectiveness analysis. JAMA 2003;290(23):3101-14.~Chadban
206 II, 5. 7. 7 | Welborn TA, Zimmet PZ, et al (2003): Prevalence of kidney damage
207 II, 5. 7. 7 | study. J Am Soc Nephrol 2003;14(7 Suppl 2):S131-S138.~
208 II, 5. 7. 7 | EL, Hogan ML, Singh AK (2003): A comparison of prediction
209 II, 5. 7. 7 | disease. J Am Soc Nephrol 2003 Oct;14(10):2573-80.~Loucks
210 II, 5. 7. 7 | disease. Am J Kidney Dis 2003;41(suppl 3):S1-S92.~National
211 II, 5. 7. 7 | disease. Am J Kidney Dis 2003;42(Suppl 3):S1-S202.~National
212 II, 5. 7. 7 | Prevention. Hypertension 2003;42(5):1050-65.~Seligman
213 II, 5. 7. 7 | Dekker FW, Simpson K, et al (2003): Trends in the incidence
214 II, 5. 7. 7 | Nephrol Dial Transplant 2003 Sep;18(9):1824-33.~Stevens
215 II, 5. 8. 2 | different entities (Fabbri et al 2003), epidemiologically, they
216 II, 5. 8. 3 | opinions (Halbert et al, 2003). Recently, a meta-analysis (
217 II, 5. 8. 3 | European respiratory Society, 2003). In EU15, 41 300 lost work
218 II, 5. 8. 3 | European Respiratory Society, 2003).~ ~ ~The total costs of
219 II, 5. 8. 4 | A study by Lundback (2003) showed that age and smoking
220 II, 5. 8. 4 | to males) (Cerveri et al, 2003).~ ~COPD has been usually
221 II, 5. 8. 4 | burden of COPD (Balmes et al, 2003). Dusty environments were
222 II, 5. 8. 5 | screening (Gorecka et al, 2003). The results showed that
223 II, 5. 8. 5 | European Respiratory Society, 2003). This publication includes
224 II, 5. 8. 7 | American Thoracic Society (2003) American Thoracic Society
225 II, 5. 8. 7 | Schwartz D, Toren K, Viegi G (2003): American Thoracic Society
226 II, 5. 8. 7 | A, Viegi G, de Marco R (2003): Chronic cough and phlegm
227 II, 5. 8. 7 | young adults. Eur Respir J 2003; 22: 413-417.~ ~Chapman
228 II, 5. 8. 7 | Negro R, Rossi A, Cerveri I (2003): The burden of COPD in
229 II, 5. 8. 7 | COPD survey. Respir Med 2003; 97: s43-50.~ ~De Marco
230 II, 5. 8. 7 | Respiratory Society (ERS) (2003). Chronic Obstructive Pulmonary
231 II, 5. 8. 7 | Ciaccia A, Saetta M, Papi A (2003): Differences in airway
232 II, 5. 8. 7 | Am J Respir Crit Care Med 2003; 167: 418–424.~ ~Furhman
233 II, 5. 8. 7 | Goljan-Geremek A, Zielinski J (2003): Diagnosis of airflow limitation
234 II, 5. 8. 7 | stop-smoking rate. Chest 2003; 123: 1916-1923.~ ~Gudmundsson
235 II, 5. 8. 7 | Isonaka S, George D, Iqbal A (2003): Interpreting COPD prevalence
236 II, 5. 8. 7 | burden of disease? Chest 2003; 123: 1684-1692.~ ~Horton
237 II, 5. 8. 7 | AL, Walk JA, Soriano JB (2003): What do chronic obstructive
238 II, 5. 8. 7 | coding analysis. Eur Respir J 2003; 22: 809-814.~ ~Jansson
239 II, 5. 8. 7 | Sandstrom T, Larsson K (2003): Obstructive Lung Disease
240 II, 5. 8. 7 | Sweden Studies. Respir Med 2003; 97: 115–122.~ ~MacNee W,
241 II, 5. 9. 1 | western lifestyle (Kim et al, 2003).~ ~In addition to the economic
242 II, 5. 9. 2 | survey. Between 2002 and 2003, two age-groups of schoolchildren
243 II, 5. 9. 3 | 2007), reported that in 2003 the prevalence of allergic
244 II, 5. 9. 3 | Lung Health in Europe, 2003 ERJ)~ ~According to the “
245 II, 5. 9. 3 | Europe Facts & Figures, 2003 ERJ). The burden of asthma
246 II, 5. 9. 3 | Lung Health in Europe, 2003).~ ~In a review of nine
247 II, 5. 9. 4 | still unclear (Custovic, 2003; Simpson , 2005; Erwin,
248 II, 5. 9. 4 | Survey I data, (Bousquet, 2003). Adults aged 20–44, living
249 II, 5. 9. 4 | allergic contact eczema) from 2003 to 2006 in a population-based
250 II, 5. 9. 7 | 1):585-92~ ~Bousquet J (2003): Allergic Rhinitis and
251 II, 5. 9. 7 | ARIA). Clin Exp All Rev 2003; 3:43-45~ ~Bo N (2006):
252 II, 5. 9. 7 | BM, Simpson A, Hallam CL (2003): Current mite, cat, and
253 II, 5. 9. 7 | J Allergy Clin Immunol. 2003 Feb;111(2):402-7.~ ~De Marco
254 II, 5. 9. 7 | Kim DS, Drake-Lee AB (2003). Infection, allergy and
255 II, 5. 9. 7 | Lung Health in Europe (2003): Facts & Figures, ERJ~ ~
256 II, 5. 9. 7 | Simpson A, Custovic A (2003): Pets and the development
257 II, 5. 9. 7 | Verlato G, de Marco R (2003): Is the prevalence of adult
258 II, 5. 9. 7 | J Allergy Clin Immunol. 2003 Jun;111(6):1232-8~ ~von
259 II, 5. 10. 1 | reactions reported (ILSI, 2003). The ranking of most frequently
260 II, 5. 10. 2 | allergens (Brusic et al, 2003; Gendel et al, 2006). The
261 II, 5. 10. 2 | databases. (Brusic et al, 2003).~ ~Table 5.10.1. Available
262 II, 5. 10. 3 | food in Europe (Gupta et al 2003), it is assumed that their
263 II, 5. 10. 5 | by Commission Directive 2003/89/EC (European Commission,
264 II, 5. 10. 5 | EC (European Commission, 2003) as regards the indication
265 II, 5. 10. 5 | of Commission Directive 2003/89/EC (European Commission,
266 II, 5. 10. 5 | EC (European Commission, 2003) specifies a list of food
267 II, 5. 10. 5 | labelling.~ ~ ~Directive 2003/89/EC~- Cereals containing
268 II, 5. 10. 5 | peoples, Commission Directive 2003/89/EC establishes, during
269 II, 5. 10. 7 | Gigonzac O, Stelman SJ (2003): Allergen databases. Allergy
270 II, 5. 10. 7 | European Commission (2003): Directive 2003/89/EC of
271 II, 5. 10. 7 | Commission (2003): Directive 2003/89/EC of the European Parliament
272 II, 5. 10. 7 | and Council of 10 November 2003 amending Directive 2000/
273 II, 5. 10. 7 | European Union L 308, 25.11.2003, pp. 15–18.~htt ~ ~European
274 II, 5. 10. 7 | Strachan D, Ross Anderson H (2003): Increasing hospital admissions
275 II, 5. 10. 7 | Sciences Institute (ILSI) (2003): Europe concise monograph
276 II, 5. 11. 3 | social costs (Dalgard et al, 2003).~Relatively few skin diseases
277 II, 5. 11. 3 | dermatitis (ACD) (CRF Azevedo, 2003). ACD is characterized by
278 II, 5. 11. 3 | Jensen et al, 2002). In 2002-2003, the Swedish market showed
279 II, 5. 11. 3 | In a study published in 2003, nickel sensitization was
280 II, 5. 11. 3 | A Schnuch, and W Uter, 2003). In the USA, where no nickel
281 II, 5. 11. 3 | Engineering Failure Analysis, 2003;10:255–263.~DV Belsito,
282 II, 5. 11. 3 | interventions, Contact Dermatitis, 2003; 49:107–108.~R Silva, F Pere a,
283 II, 5. 11. 3 | frequent in men (Ceylan et al, 2003).~In Vaud, Switzerland,
284 II, 5. 11. 3 | countries (Boyle and Smans, 2003).~Both basal cell carcinoma
285 II, 5. 11. 3 | rising (De Vries et al, 2003). The net effect is that
286 II, 5. 11. 3 | Portugal (Boyle and Smans, 2003).~Melanoma is at least to
287 II, 5. 11. 7 | 5-6.~ ~Boyle P, Smans M (2003): Cancer Mortality Atlas
288 II, 5. 11. 7 | Oxford University Press, 2003.~ ~Ceylan C, Ozturk G, Alper
289 II, 5. 11. 7 | Ceylan C, Ozturk G, Alper S (2003): Non-melanomatous skin
290 II, 5. 11. 7 | characteristics. J Dermatol 2003;30:123–131.~ ~Dalgard F,
291 II, 5. 11. 7 | Dalgard F, Svensson A, et al (2003): Self-reported skin complaints:
292 II, 5. 11. 7 | population surveys. Br J Dermatol 2003;149:794-800.~ ~de Rijke
293 II, 5. 11. 7 | Coebergh JW, Parkin DM (2003): Changing epidemiology
294 II, 5. 11. 7 | Scandinavia. Int J Cancer 2003;107:119–126.~ ~Diepgen TL,
295 II, 5. 12. 3 | al, 2005; Ioannou et al, 2003; Poynard et al, 1999; Sauer
296 II, 5. 12. 7 | Ioannou G, Doust J, Rockey DC (2003): Terlipressin for acute
297 II, 5. 13 | culture (European Commission, 2003).~ ~Excess body weight associated
298 II, 5. 14. 1 | diabetes (Bourgeois and Baehni, 2003).~ ~Recently in Europe,
299 II, 5. 14. 3 | uncommon condition in France (2003). Most localized forms were
300 II, 5. 14. 8 | Indicators Development Project. 2003 Report Proceedings. Paris:
301 II, 5. 14. 8 | Indicators Development Project. 2003 Report Proceedings, eds
302 II, 5. 15. 4 | January 1999 to 31 December 2003 with the aim of ensuring
303 II, 5. 15. 4 | Public Health Programme 2003-2008. The two main lines
304 II, 6. 3. 1 | sectors other than health. The 2003 SARS outbreak cost some
305 II, 6. 3. 4 | was higher than during the 2003–04 season, but lower or
306 II, 6. 3. 4 | but lower or equal to the 2003–04 season in the other 13
307 II, 6. 3. 4 | global threat in mid-March 2003 in East Asia. By July 2003,
308 II, 6. 3. 4 | 2003 in East Asia. By July 2003, the international spread
309 II, 6. 3. 5 | increase between 2001 and 2003. The incidence rates were
310 II, 6. 3. 5 | Netherlands (1999–2000), Spain (2003), Poland (1998) and Lithuania (
311 II, 6. 3. 7 | Czech Republic (1997) and France (2003) affecting five and seven
312 II, 6. 3. 7 | from Sierra Leone (2000 and 2003), one case in the Netherlands
313 II, 7. 3 | Union, Statistics summary 2003 – 2005” (see KfV, 2007)1.
314 II, 7. 3 | years, mostly for the period 2003-2005.~ ~
315 II, 7. 3. 2 | throughout the EU. Based on the 2003-2005 figures for all ages,
316 II, 7. 3. 3 | discharges due to injuries, EU27, 2003-2005~ ~On average about
317 II, 7. 4. 4 | the time of injury, EU27, 2003-2005~ ~The “sport injuries”
318 II, 7. 4. 4 | of injury by age group, 2003-2005~ ~Physical exercise
319 II, 7. 7 | PT, SI, SE (2004) EE, IT (2003) [https://www.unav.es/preventiva/
320 II, 7. 7 | IT, FI. 3 year average of 2003-2005. [https://webgate.ec.
321 II, 7. 7 | Union - Statistics Summary 2003-2005. Vienna: Austrian Road
322 II, 8. 1. 3 | occupational achievements.~ ~In 2003 the proportion of men in
323 II, 8. 1. 5 | adopted on 30th of October 2003 a Communication regarding
324 II, 8. 1. 5 | People with Disabilities 2003. This Communication on "
325 II, 8. 1. 5(5) | COM(2003)650 http ml~
326 II, 8. 2. 1 | between the years 2000 to 2003. The scope of the surveys
327 II, 8. 2. 1 | of 1.1% (Heikura et al, 2003). A similar prevalence of
328 II, 8. 2. 1 | impairments (Arvio and Sillanpää, 2003).~ ~In Aarhus (Denmark)
329 II, 8. 2. 1 | 295-304.~Kramers, P.G.N., (2003). The ECHI project: Health
330 II, 8. 2. 1 | Schrojenstein Lantman-de Valk HMJ (2003): Health indicators for
331 II, 8. 2. 2 | visual impairment proposed in 2003 by a WHO consultation on
332 II, 8. 2. 2 | better than 3/60) (WHO, 2003). Blindness is defined as
333 II, 8. 2. 2 | document WHO/PBL/00.77.~WHO (2003): Prevention of blindness
334 II, 8. 2. 2 | functioning. Geneva 4-5 September 2003. Document WHO/PBL/03.91~
335 II, 8. 2. 3 | features in Mathers et al, 2003). In Europe, surveys have
336 II, 8. 2. 3 | Johansson and Arlinger, 2003; Karlsmose et al, 1999;
337 II, 8. 2. 3 | severity (Mathers et al, 2003). The results obtained are
338 II, 8. 2. 3 | Johansson and Arlinger, 2003) showed that 16.9% subjects
339 II, 8. 2. 3 | belong) (Mathers et al, 2003).~The burden of disability
340 II, 8. 2. 3 | Johansson MSK, Arlinger SD (2003): Prevalence of hearing
341 II, 8. 2. 3 | International J Audiology. 2003;42:18-28~ ~Karlsmose B,
342 II, 8. 2. 3 | Mathers C, Smith A, Concha M (2003): Global burden of hearing
343 II, 9 | pregnancies (Kahn et al, 2003; Luke and Brown, 2007b;
344 II, 9 | 1997; Dolk and Vrijheid, 2003; EUROCAT, 2004). To protect
345 II, 9 | mothers (European Commission, 2003). Poor health behaviour
346 II, 9 | sexes (European Commission, 2003). In conducting the research
347 II, 9 | replacement therapy (Beral, 2003), and higher body mass index (
348 II, 9 | Source: Pomerleau et al, 2003: p. 455~ ~Levels of physical activity
349 II, 9. 1 | perinatal origin (Cans et al, 2003). Maternal deaths occur
350 II, 9. 1. 1 | and Norway (Zeitlin et al, 2003). The resulting EURO-PERISTAT
351 II, 9. 1. 1 | M, Vutuc C, Lindmark G (2003): Maternal health outcomes
352 II, 9. 1. 1 | Obstet Gynecol Reprod Biol 2003;111 Suppl 1:S78-87.~ ~Alran
353 II, 9. 1. 1 | Barros H, Wagener Y, Prati S (2003): Characteristics of the
354 II, 9. 1. 1 | Obstet Gynecol Reprod Biol 2003;111 Suppl 1:S45-52.~ ~Cans
355 II, 9. 1. 1 | Fauconnier J, Rambaud P, Jouk PS (2003): Disabilities and trends
356 II, 9. 1. 1 | 1980-91. Arch Dis Child 2003;88(2):114-7.~Canterino JC,
357 II, 9. 1. 1 | Cleary-Goldman J, D'Alton ME, et al (2003): Prospective risk of fetal
358 II, 9. 1. 1 | practice. Obstet Gynecol 2003;102(4):685-92.~Kaminski
359 II, 9. 1. 1 | Barros H, Blondel B, et al (2003): Selecting an indicator
360 II, 9. 1. 1 | Obstet Gynecol Reprod Biol 2003;111 Suppl 1:S5-S14.~ ~
361 II, 9. 1. 2 | pregnancies (Kahn et al, 2003; Luke and Brown, 2007b;
362 II, 9. 1. 2 | 1997; Dolk and Vrijheid, 2003; EUROCAT, 2004). To protect
363 II, 9. 1. 2 | Barros H, Wagener Y, Prati S (2003): Characteristics of the
364 II, 9. 1. 2 | 402.~Dolk H, Vrijheid M (2003): "The Impact of Environmental
365 II, 9. 2. 2 | Köhler, 2002; Rigby et al, 2003). This was charged with
366 II, 9. 2. 3 | Finland (European Commission, 2003), although in November 2006
367 II, 9. 2. 4 | mothers (European Commission, 2003). Poor health behaviour
368 II, 9. 2. 4 | sexes (European Commission, 2003). In conducting the research
369 II, 9. 2. 5 | Programme in Public Health 2003-2008 (European Parliament
370 II, 9. 2. 7 | 2000~ ~European Commission (2003): The Health Status of the
371 II, 9. 2. 7 | field of public health (2003-2008), OJ No L 271, 9 October
372 II, 9. 3. 1 | across Europe (White & Cash, 2003) and there have been to
373 II, 9. 3. 1 | Health Forum (White & Cash 2003).~ ~There are also difficulties
374 II, 9. 3. 1 | lost) (European Commission, 2003). These accidents are estimated
375 II, 9. 3. 1 | people (European Commission 2003). The disease usually first
376 II, 9. 3. 1 | 1 000 inhabitants. In a 2003 report, the European Commission
377 II, 9. 3. 1 | 20% (European Commission, 2003). Hypertension is both a
378 II, 9. 3. 1 | 65 (European Commission, 2003). For both sexes of all
379 II, 9. 3. 1 | respectively (European Commission, 2003).~ ~Peripheral vascular
380 II, 9. 3. 1 | Greece (European Commission, 2003). The Netherlands report
381 II, 9. 3. 1 | that posed by smoking (WHO, 2003).~ ~The Obesity in Europe
382 II, 9. 3. 1 | Europe (European Commission, 2003). The two main transmission
383 II, 9. 3. 1 | AIDS) (European Commission, 2003), but 24,184 newly diagnosed
384 II, 9. 3. 1 | gender inequality (Brown, 2003). UNAIDS has observed that
385 II, 9. 3. 1 | disability (European Commission, 2003).~ ~Menopause~ ~Climateric.
386 II, 9. 3. 1 | previously thought (Boyle et al 2003). The causes are mainly
387 II, 9. 3. 1 | replacement therapy (Beral, 2003), and higher body mass index (
388 II, 9. 3. 1 | Source: Pomerleau et al, 2003: p. 455~ ~Levels of physical activity
389 II, 9. 3. 1 | 1): p. 50-56.~ ~Beral V (2003): Breast cancer and hormone-replacement
390 II, 9. 3. 1 | the UrEpik Study Group (2003) The prevalence of male
391 II, 9. 3. 1 | 54(5): 328-332~ ~Brown H (2003): Women's Lack of Control
392 II, 9. 3. 1 | http://www.prb.org/Articles/2003/WomensLackofControlOverSTIRisksDrivesMicrobicideSearch.
393 II, 9. 3. 1 | European Commission (2003): The Health Status of the
394 II, 9. 3. 1 | Community/Europe Against Cancer (2003): European Code Against
395 II, 9. 3. 1 | 6.~ ~White AK , Cash K (2003): The state of men’s health
396 II, 9. 3. 1 | Europe. Copenhagen~ ~WHO (2003) Controlling the global
397 II, 9. 3. 2 | morbidity (Alexander et al, 2003). The causes of maternal
398 II, 9. 3. 2 | for the two-year period 2003 and 2004, there is a substantial
399 II, 9. 3. 2 | feasibility study (Breart et al, 2003). More recent data, collected
400 II, 9. 3. 2 | M, Vutuc C, Lindmark G (2003): Maternal health outcomes
401 II, 9. 3. 2 | Obstet Gynecol Reprod Biol 2003;111 Suppl 1:S78-87.~ ~Alran
402 II, 9. 3. 2 | Barros H, Wagener Y, Prati S (2003): Characteristics of the
403 II, 9. 3. 2 | Obstet Gynecol Reprod Biol 2003;111 Suppl 1:S45-52.~ ~Cans
404 II, 9. 3. 2 | Fauconnier J, Rambaud P, Jouk PS (2003): Disabilities and trends
405 II, 9. 3. 2 | 1980-91. Arch Dis Child 2003;88(2):114-7.~ ~Canterino
406 II, 9. 3. 2 | Cleary-Goldman J, D'Alton ME, et al (2003): Prospective risk of fetal
407 II, 9. 3. 2 | practice. Obstet Gynecol 2003;102(4):685-92.~ ~Kaminski
408 II, 9. 3. 2 | Barros H, Blondel B, et al (2003): Selecting an indicator
409 II, 9. 3. 2 | Obstet Gynecol Reprod Biol 2003;111 Suppl 1:S5-S14.~ ~ ~
410 II, 9. 3. 3 | STIs/HIV/AIDS (Bajos et al, 2003). The study data are based
411 II, 9. 3. 3 | Haavio-Mannila and Kontula, 2003; Nikula et al, 2007), Portugal (
412 II, 9. 3. 3 | UK, at 16.2 (Bajos et al, 2003); the increase in the proportion
413 II, 9. 3. 3 | the 1990s (Bajos et al, 2003). At variance, in Ireland
414 II, 9. 3. 3 | to the ‘80s (Bajos et al, 2003). In all of these Countries,
415 II, 9. 3. 3 | youngest cohorts (Bajos et al, 2003; Nikula et al, 2007). Also
416 II, 9. 3. 3 | stable between 1993 and 2003 at 18 years of age for both
417 II, 9. 3. 3 | the 1990s (Bajos et al, 2003). As a consequence of the
418 II, 9. 3. 3 | has decreased from 1993 to 2003 from about 11 to about 9
419 II, 9. 3. 3 | than women (Bajos et al, 2003; Nikula et al, 2007), but
420 II, 9. 3. 3 | 1998, decreased again in 2003 (Weiss,2008).~ ~It has been
421 II, 9. 3. 3 | lives (European Parliament, 2003).~ ~Individual-based interventions
422 II, 9. 3. 3 | Guillaume A, Kontula O (2003): Reproductive behaviour
423 II, 9. 3. 3 | 66.~European Parliament (2003): Resolution on sexual and
424 II, 9. 3. 3 | Journal C 271 E , 12/11/2003 P. 0369 - 0374~Facultes
425 II, 9. 3. 3 | Encounter Module Project. May 13 2003. Available at: htt l (accessed
426 II, 9. 3. 3 | Haavio-Mannila E, Kontula O (2003) Sexual trends in the Baltic
427 II, 9. 3. 3 | sexual risk in Sweden (1989-2003). Arch Sex Behav 34:219-
428 II, 9. 3. 3 | each year 1993, 1998 and 2003.~Wellings K, Nanchahak K,
429 II, 9. 3. 3 | births in England, 1994-2003, and the national teenage
430 II, 9. 4. 1 | sustainability (European Commission, 2003). Research stresses the
431 II, 9. 4. 3 | rate (European Commission, 2003). The ‘elderly index’ (obtained
432 II, 9. 4. 3 | disease (European Commission, 2003). The most common causes
433 II, 9. 4. 3 | Luxembourg) (European Commission, 2003). The highest rates of suicide
434 II, 9. 4. 3 | European Health Men’s Forum, 2003). Morbidity for Coronary
435 II, 9. 4. 3 | European Health Men’s Forum, 2003).~ ~Stroke. Recurrent strokes
436 II, 9. 4. 3 | International Diabetes Federation, 2003). Long-term complications
437 II, 9. 4. 3 | age) (DECODE Study Group, 2003). In 70 to 79 year olds,
438 II, 9. 4. 3 | cases, between 1995 and 2003, whilst cases of gonorrhoea
439 II, 9. 4. 3 | 249%, from 39 to 136. In 2003, women over 40 made up 7%
440 II, 9. 4. 3 | susceptibility to STIs (Mahar, 2003).~ ~ ~Daily life-limiting
441 II, 9. 4. 5 | children (European Commission, 2003).~ ~Acute Geriatric Medicine.
442 II, 9. 4. 5 | was adopted on 20 February 2003 (6528/03). The replies from
443 II, 9. 4. 5 | come into force in January 2003, will be usefule for developing
444 II, 9. 4. 7 | Diabetes Epidemiology Group (2003): Is the current definition
445 II, 9. 4. 7 | non-cardiovascular disease?Diabetes Care 2003;26:688-696.~ ~EPHA briefing
446 II, 9. 4. 7 | European Commission (2003): The Health Status of the
447 II, 9. 4. 7 | European Men’s Health Forum (2003): A report on the state
448 II, 9. 4. 7 | International Diabetes Federation (2003): World Diabetes Day. United
449 II, 9. 4. 7 | 3(3):94-98~ ~Mahar, F (2003): Sexually transmitted infections
450 II, 9. 4. 7 | Volume 9, Number 4, December 2003 , pp. 173-174(2)~ ~Mukaetova-Ladinska
451 II, 9. 4. 7 | Health Programme~ ~WHO (2003): Atlas of Health in Europe~ ~
452 II, 9. 5. 3 | percentage of the labour force, 2003~ ~In most countries, the
453 II, 9. 5. 3 | allergies (European Commission, 2003). By contrast, males suffer
454 II, 9. 5. 3 | mothers (European Commission, 2003). Education is also significantly
455 II, 9. 5. 3 | upper secondary education (2003)~ ~Poverty in old age~ ~
456 II, 9. 5. 3 | Metropolitan University, 2003 ~ ~ ~ ~B. Information of
457 II, 9. 5. 3 | Spain, 2002; b Joni Sager, 2003; c Women’s issues Information
458 II, 9. 5. 3 | replacement therapy (Beral, 2003), and higher body mass index (
459 II, 9. 5. 3 | Smoking in 1985 and 2002-2003~ ~The issues around quitting
460 II, 9. 5. 3 | culture (European Commission, 2003).~ ~It is more commonly
461 II, 9. 5. 3 | male and female (Paechter, 2003).~ ~Feelings of dissatisfaction
462 II, 9. 5. 4 | information is essential (Brown, 2003). Most effective however,
463 II, 9. 5. 4 | screening guidelines (COM (2003) 0230, Proposal for a Council
464 II, 9. 5. 6 | RoutledgeFalmer.~ ~Beral V 2003: Breast cancer and hormone-replacement
465 II, 9. 5. 6 | of Education~ ~Brown H (2003): Women's Lack of Control
466 II, 9. 5. 6 | http://www.prb.org/Articles/2003/WomensLackofControlOverSTIRisksDrivesMicrobicideSearch.
467 II, 9. 5. 6 | Christen AG, Christen JA (2003): The female smoker: from
468 II, 9. 5. 6 | Safety and Health at Work (2003): Gender issues in safety
469 II, 9. 5. 6 | Luxembourg~ ~European Commission (2003): The Health Status of the
470 II, 9. 5. 6 | Commission/Europe Against Cancer (2003): European Code Against
471 II, 9. 5. 6 | 16.07.07)~ ~Paechter C (2003): Power, Bodies and Identity:
472 III, 10. 1. 1 | Titchenal, 1988; Tappy et al, 2003). The type, intensity, frequency
473 III, 10. 1. 1 | exercise on diet. (Tappy et al, 2003) Within the normal activity
474 III, 10. 1. 1 | influential (Gmel and Rehm, 2003; Milgram, 1993; Taylor and
475 III, 10. 1. 3 | 2581-2590.~Gmel G, Rehm J (2003): Harmful alcohol use. Alcohol
476 III, 10. 1. 3 | Binnert C, Schneiter Ph (2003): Energy expenditure, physical activity
477 III, 10. 2. 1 | smoking between 2000 and 2003, while Belgium recorded
478 III, 10. 2. 1 | European Commission, 2003).~In 1990–1994, the self-reported
479 III, 10. 2. 1 | 14 hours per day (ENSP, 2003).~ ~Health impact of smokeless
480 III, 10. 2. 1 | unequivocally clear. (ENSP, 2003).~ ~
481 III, 10. 2. 1 | legalizing snuff (Bates et al, 2003).~The critics of this approach
482 III, 10. 2. 1 | and Gilmore, 2007; ENSP, 2003). The Swedish experience
483 III, 10. 2. 1 | attributed to the success of the 2003 EU directive banning tobacco
484 III, 10. 2. 1 | McNeill A, Ramström L (2003): European Union policy
485 III, 10. 2. 1 | Zatonski W, zur Hausen H (2003): European Code Against
486 III, 10. 2. 1 | justification: third version (2003). Annals of Oncology; 14:
487 III, 10. 2. 1 | European Commission (2003): European Opinion Research
488 III, 10. 2. 1 | and the Environment (EEIG, 2003): Actions and Attitudes.
489 III, 10. 2. 1 | Attitudes. Special Eurobarometer 2003; 183. Available at:~htt ~ ~
490 III, 10. 2. 1 | Smoking Prevention (ENSP) (2003): Status Report on Oral
491 III, 10. 2. 1 | remained the same in 2006 as in 2003 (10%). However, given that
492 III, 10. 2. 1 | 2006 compared to 61% in 2003, the actual number of EU15
493 III, 10. 2. 1 | increased by 10% between 2003 and 2006.~ ~Nearly all (
494 III, 10. 2. 1 | years of age. Data from the 2003 European School Survey Project
495 III, 10. 2. 1 | Europe per cost element (year 2003)~ ~
496 III, 10. 2. 1 | advocacy groups (Babor et al, 2003). In the context of public
497 III, 10. 2. 1 | assault injuries (Giesbrecht, 2003). Community mobilization
498 III, 10. 2. 1 | Safety Action Programme 2003-2010~http ~ ~European Commission
499 III, 10. 2. 1 | Public Health Programme 2003-2008:~ ~PHEPA: Primary Health
500 III, 10. 2. 1 | J, Room R and Rossow I (2003): Alcohol: No Ordinary Commodity.
|
|
| |
